What Is HPLC? How Peptide Purity Is Actually Measured

Every chromatographic separation is a competition between two phases:

• The stationary phase — the packing material inside the column, typically silica particles a few micrometers across, chemically bonded with hydrocarbon chains.
• The mobile phase — the solvent mixture pumped continuously through the column, carrying the sample with it.

A molecule injected into that system partitions between the two: time spent interacting with the stationary phase is time not moving, so molecules that interact more strongly emerge later. The time from injection to emergence is that component's retention time, and under fixed conditions it is characteristic and reproducible.

"High-performance" refers to the pressure. Packing a column with very fine particles creates enormous surface area for separation but also enormous resistance to flow — modern systems run at hundreds of bar to push solvent through at usable rates. Finer particles, higher pressure, sharper separations.

Peptide analysis almost always uses reverse-phase HPLC, and the name is historical: "normal phase" meant a polar stationary phase with a nonpolar solvent, so reversing it — nonpolar stationary phase, polar solvent — earned the inverted label.

In practice that means a C18 column (silica bonded with 18-carbon alkyl chains, giving a strongly hydrophobic surface) run with a water/acetonitrile mobile phase, usually with a small amount of trifluoroacetic acid as an ion-pairing agent. Separation is then driven by hydrophobicity: peptides whose exposed residues are more hydrophobic stick harder to the C18 surface and elute later.

Most peptide methods run a gradient — starting with a mostly aqueous mobile phase and increasing the organic fraction over the run. Early in the gradient only the least hydrophobic species can travel; as acetonitrile rises, progressively stickier species release from the column in sequence. This is what makes reverse-phase HPLC so well suited to peptides: closely related species — a target peptide and a variant missing a single residue, or one oxidized at a single site — differ just enough in hydrophobicity to separate.

The detector output is a plot of signal against time. For peptides, detection is usually UV absorbance around 214 nm, where the peptide bond itself absorbs — meaning the detector responds to peptide backbone, not to any particular sequence.

Each peak is a component reaching the detector; its position on the time axis is its retention time; its area is proportional to how much of that component passed through.

Purity is calculated from areas, not heights. The standard convention:

purity (%) = (area of the main peak ÷ total area of all peaks) × 100

So "99.1% by HPLC" means the main peak accounted for 99.1% of all detected peak area under that method. Everything else on the trace — the small peaks before and after — is the remaining 0.9%: synthesis-related impurities, degradation products, or process residues.

HPLC measures how much, not what. Chromatography separates and quantifies, but a peak is just a species with a retention time. It does not say what the main peak is. Confirming that the dominant species is actually the intended peptide requires mass spectrometry, which measures molecular weight directly — the reason a complete Certificate of Analysis reports both, purity by HPLC and identity by MS.

The number is method-dependent. Different columns, gradients, and detection wavelengths can produce different purity figures on the same sample — usually similar, occasionally not. A purity value is only fully meaningful alongside the method that produced it, which is why serious reports include chromatographic conditions rather than a bare percentage.

Detection has blind spots. UV at 214 nm sees peptide bonds. Species without them — residual salts, counterions, solvents, water — are largely invisible to the detector and therefore excluded from a peak-area calculation entirely. This is precisely why peptide purity and peptide content are different numbers: a 99% pure peptide can still be a substantial fraction of vial mass in counterion and residual water. Both figures answer real questions; neither substitutes for the other.

Co-elution is the honest caveat. If two species happen to have nearly identical retention under a given method, they emerge as one peak and are counted as one component. Well-developed methods are validated to resolve the impurities they're likely to encounter — another reason methodology matters more than the headline figure.

For a research-peptide lot, HPLC does the quantitative work: it establishes the proportion of the material that is the intended species and makes the impurity profile visible as a set of resolved peaks. Mass spectrometry then answers the identity question. Together they are the two-method backbone of the documentation HEEZ publishes: independent third-party HPLC purity and mass-spectrometry identity confirmation, with Certificates of Analysis published on product pages as testing is completed — review the report before you order.

For a worked example of how these numbers appear on an actual report, see the annotated documentation section on our homepage, or browse compound-level chemistry in the research library.